nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD2—nicotine dependence	0.596	1	CbGaD
Pramipexole—Bradyphrenia—Varenicline—nicotine dependence	0.00734	0.0292	CcSEcCtD
Pramipexole—Dissociation—Varenicline—nicotine dependence	0.00685	0.0272	CcSEcCtD
Pramipexole—Snoring—Varenicline—nicotine dependence	0.00685	0.0272	CcSEcCtD
Pramipexole—Postnasal drip—Varenicline—nicotine dependence	0.00643	0.0255	CcSEcCtD
Pramipexole—Middle insomnia—Varenicline—nicotine dependence	0.00606	0.0241	CcSEcCtD
Pramipexole—Upper-airway cough syndrome—Varenicline—nicotine dependence	0.00544	0.0216	CcSEcCtD
Pramipexole—Initial insomnia—Varenicline—nicotine dependence	0.00544	0.0216	CcSEcCtD
Pramipexole—Somnambulism—Varenicline—nicotine dependence	0.00495	0.0197	CcSEcCtD
Pramipexole—Panic reaction—Varenicline—nicotine dependence	0.00495	0.0197	CcSEcCtD
Pramipexole—Myopia—Varenicline—nicotine dependence	0.00455	0.0181	CcSEcCtD
Pramipexole—Rhinitis allergic—Varenicline—nicotine dependence	0.00438	0.0174	CcSEcCtD
Pramipexole—Vitreous floaters—Varenicline—nicotine dependence	0.00438	0.0174	CcSEcCtD
Pramipexole—Pleurisy—Varenicline—nicotine dependence	0.00407	0.0162	CcSEcCtD
Pramipexole—Joint stiffness—Varenicline—nicotine dependence	0.00329	0.0131	CcSEcCtD
Pramipexole—Sensory disturbance—Varenicline—nicotine dependence	0.00321	0.0127	CcSEcCtD
Pramipexole—Facial paralysis—Varenicline—nicotine dependence	0.00313	0.0124	CcSEcCtD
Pramipexole—Respiratory tract congestion—Varenicline—nicotine dependence	0.00272	0.0108	CcSEcCtD
Pramipexole—Varicose vein—Varenicline—nicotine dependence	0.00267	0.0106	CcSEcCtD
Pramipexole—Abnormal behaviour—Varenicline—nicotine dependence	0.00267	0.0106	CcSEcCtD
Pramipexole—Drug hypersensitivity—Varenicline—nicotine dependence	0.00247	0.00981	CcSEcCtD
Pramipexole—Haematochezia—Varenicline—nicotine dependence	0.00247	0.00981	CcSEcCtD
Pramipexole—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00242	0.00963	CcSEcCtD
Pramipexole—Dysphoria—Varenicline—nicotine dependence	0.0023	0.00913	CcSEcCtD
Pramipexole—Aphthous stomatitis—Varenicline—nicotine dependence	0.00212	0.00842	CcSEcCtD
Pramipexole—Myositis—Varenicline—nicotine dependence	0.00203	0.00805	CcSEcCtD
Pramipexole—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00203	0.00805	CcSEcCtD
Pramipexole—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00203	0.00805	CcSEcCtD
Pramipexole—Sinus congestion—Varenicline—nicotine dependence	0.002	0.00794	CcSEcCtD
Pramipexole—Suicide—Varenicline—nicotine dependence	0.00192	0.00761	CcSEcCtD
Pramipexole—DRD4—brain—nicotine dependence	0.00184	0.0692	CbGeAlD
Pramipexole—Night sweats—Varenicline—nicotine dependence	0.00184	0.00732	CcSEcCtD
Pramipexole—Balance disorder—Varenicline—nicotine dependence	0.00182	0.00723	CcSEcCtD
Pramipexole—Osteoporosis—Varenicline—nicotine dependence	0.00177	0.00705	CcSEcCtD
Pramipexole—Sexual dysfunction—Varenicline—nicotine dependence	0.00177	0.00705	CcSEcCtD
Pramipexole—Gastric ulcer—Varenicline—nicotine dependence	0.00171	0.0068	CcSEcCtD
Pramipexole—Completed suicide—Varenicline—nicotine dependence	0.00169	0.00672	CcSEcCtD
Pramipexole—Libido increased—Varenicline—nicotine dependence	0.00163	0.00649	CcSEcCtD
Pramipexole—Toothache—Varenicline—nicotine dependence	0.00163	0.00649	CcSEcCtD
Pramipexole—Vaginal discharge—Varenicline—nicotine dependence	0.00163	0.00649	CcSEcCtD
Pramipexole—Psoriasis—Varenicline—nicotine dependence	0.00158	0.00628	CcSEcCtD
Pramipexole—Parosmia—Varenicline—nicotine dependence	0.00153	0.00609	CcSEcCtD
Pramipexole—HTR1B—cardiovascular system—nicotine dependence	0.00153	0.0575	CbGeAlD
Pramipexole—Upset stomach—Varenicline—nicotine dependence	0.00152	0.00603	CcSEcCtD
Pramipexole—HTR1D—cardiovascular system—nicotine dependence	0.00148	0.0556	CbGeAlD
Pramipexole—DRD1—midbrain—nicotine dependence	0.00148	0.0554	CbGeAlD
Pramipexole—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00147	0.00585	CcSEcCtD
Pramipexole—Paranoia—Varenicline—nicotine dependence	0.00146	0.0058	CcSEcCtD
Pramipexole—Intestinal obstruction—Varenicline—nicotine dependence	0.00146	0.0058	CcSEcCtD
Pramipexole—Laryngeal pain—Varenicline—nicotine dependence	0.00146	0.0058	CcSEcCtD
Pramipexole—Haematemesis—Varenicline—nicotine dependence	0.00143	0.00569	CcSEcCtD
Pramipexole—Suicidal ideation—Varenicline—nicotine dependence	0.00142	0.00563	CcSEcCtD
Pramipexole—Delusion—Varenicline—nicotine dependence	0.0014	0.00558	CcSEcCtD
Pramipexole—Thrombosis—Varenicline—nicotine dependence	0.0014	0.00558	CcSEcCtD
Pramipexole—Nystagmus—Varenicline—nicotine dependence	0.00139	0.00553	CcSEcCtD
Pramipexole—HTR2B—cardiovascular system—nicotine dependence	0.00138	0.0518	CbGeAlD
Pramipexole—Hyperlipidaemia—Varenicline—nicotine dependence	0.00138	0.00548	CcSEcCtD
Pramipexole—Mania—Varenicline—nicotine dependence	0.00137	0.00543	CcSEcCtD
Pramipexole—Menorrhagia—Varenicline—nicotine dependence	0.00134	0.00534	CcSEcCtD
Pramipexole—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00132	0.00525	CcSEcCtD
Pramipexole—Scotoma—Varenicline—nicotine dependence	0.00131	0.0052	CcSEcCtD
Pramipexole—DRD3—brain—nicotine dependence	0.0013	0.0486	CbGeAlD
Pramipexole—Fungal infection—Varenicline—nicotine dependence	0.00129	0.00512	CcSEcCtD
Pramipexole—Gingivitis—Varenicline—nicotine dependence	0.00127	0.00503	CcSEcCtD
Pramipexole—Nephrolithiasis—Varenicline—nicotine dependence	0.00124	0.00491	CcSEcCtD
Pramipexole—HTR1A—cardiovascular system—nicotine dependence	0.00124	0.0464	CbGeAlD
Pramipexole—Glycosuria—Varenicline—nicotine dependence	0.00123	0.00488	CcSEcCtD
Pramipexole—Rhinorrhoea—Varenicline—nicotine dependence	0.00123	0.00488	CcSEcCtD
Pramipexole—DRD5—brain—nicotine dependence	0.00121	0.0456	CbGeAlD
Pramipexole—Dysphonia—Varenicline—nicotine dependence	0.00121	0.0048	CcSEcCtD
Pramipexole—Endocrine disorder—Varenicline—nicotine dependence	0.0012	0.00477	CcSEcCtD
Pramipexole—HTR1B—midbrain—nicotine dependence	0.0012	0.0449	CbGeAlD
Pramipexole—Acne—Varenicline—nicotine dependence	0.00118	0.00469	CcSEcCtD
Pramipexole—Eye irritation—Varenicline—nicotine dependence	0.00116	0.00463	CcSEcCtD
Pramipexole—HTR1D—midbrain—nicotine dependence	0.00116	0.0435	CbGeAlD
Pramipexole—Disturbance in attention—Varenicline—nicotine dependence	0.00115	0.00456	CcSEcCtD
Pramipexole—HTR2C—midbrain—nicotine dependence	0.00115	0.043	CbGeAlD
Pramipexole—Aggression—Varenicline—nicotine dependence	0.00113	0.0045	CcSEcCtD
Pramipexole—Accidental injury—Varenicline—nicotine dependence	0.00112	0.00446	CcSEcCtD
Pramipexole—Chest discomfort—Varenicline—nicotine dependence	0.00112	0.00446	CcSEcCtD
Pramipexole—Viral infection—Varenicline—nicotine dependence	0.0011	0.00437	CcSEcCtD
Pramipexole—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0011	0.00437	CcSEcCtD
Pramipexole—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0011	0.00437	CcSEcCtD
Pramipexole—Lacrimation increased—Varenicline—nicotine dependence	0.00108	0.00429	CcSEcCtD
Pramipexole—Nocturia—Varenicline—nicotine dependence	0.00107	0.00426	CcSEcCtD
Pramipexole—Leukocytosis—Varenicline—nicotine dependence	0.00106	0.0042	CcSEcCtD
Pramipexole—Dysarthria—Varenicline—nicotine dependence	0.00105	0.00418	CcSEcCtD
Pramipexole—Coordination abnormal—Varenicline—nicotine dependence	0.00101	0.00402	CcSEcCtD
Pramipexole—Musculoskeletal pain—Varenicline—nicotine dependence	0.00101	0.004	CcSEcCtD
Pramipexole—Pulmonary embolism—Varenicline—nicotine dependence	0.000994	0.00395	CcSEcCtD
Pramipexole—Abnormal dreams—Varenicline—nicotine dependence	0.000982	0.0039	CcSEcCtD
Pramipexole—Eructation—Varenicline—nicotine dependence	0.000977	0.00388	CcSEcCtD
Pramipexole—HTR1A—midbrain—nicotine dependence	0.000965	0.0362	CbGeAlD
Pramipexole—Influenza like illness—Varenicline—nicotine dependence	0.000965	0.00384	CcSEcCtD
Pramipexole—Salivary hypersecretion—Varenicline—nicotine dependence	0.000965	0.00384	CcSEcCtD
Pramipexole—Nightmare—Varenicline—nicotine dependence	0.00096	0.00381	CcSEcCtD
Pramipexole—Photophobia—Varenicline—nicotine dependence	0.000933	0.00371	CcSEcCtD
Pramipexole—DRD1—brain—nicotine dependence	0.000928	0.0348	CbGeAlD
Pramipexole—Dry eye—Varenicline—nicotine dependence	0.000918	0.00365	CcSEcCtD
Pramipexole—Oesophagitis—Varenicline—nicotine dependence	0.000908	0.00361	CcSEcCtD
Pramipexole—DRD2—midbrain—nicotine dependence	0.000872	0.0327	CbGeAlD
Pramipexole—Hypertonia—Varenicline—nicotine dependence	0.000871	0.00346	CcSEcCtD
Pramipexole—Euphoric mood—Varenicline—nicotine dependence	0.000854	0.00339	CcSEcCtD
Pramipexole—ADRA2C—midbrain—nicotine dependence	0.000848	0.0318	CbGeAlD
Pramipexole—Lymphadenopathy—Varenicline—nicotine dependence	0.000846	0.00336	CcSEcCtD
Pramipexole—Sleep disorder—Varenicline—nicotine dependence	0.000834	0.00331	CcSEcCtD
Pramipexole—Diabetes mellitus—Varenicline—nicotine dependence	0.00083	0.0033	CcSEcCtD
Pramipexole—Deafness—Varenicline—nicotine dependence	0.000807	0.00321	CcSEcCtD
Pramipexole—Disorientation—Varenicline—nicotine dependence	0.000807	0.00321	CcSEcCtD
Pramipexole—Eczema—Varenicline—nicotine dependence	0.000803	0.00319	CcSEcCtD
Pramipexole—Eye pain—Varenicline—nicotine dependence	0.000799	0.00318	CcSEcCtD
Pramipexole—Injury—Varenicline—nicotine dependence	0.000785	0.00312	CcSEcCtD
Pramipexole—Libido decreased—Varenicline—nicotine dependence	0.000778	0.00309	CcSEcCtD
Pramipexole—Hot flush—Varenicline—nicotine dependence	0.000771	0.00307	CcSEcCtD
Pramipexole—Increased appetite—Varenicline—nicotine dependence	0.000768	0.00305	CcSEcCtD
Pramipexole—Amnesia—Varenicline—nicotine dependence	0.000768	0.00305	CcSEcCtD
Pramipexole—Menopausal symptoms—Varenicline—nicotine dependence	0.000765	0.00304	CcSEcCtD
Pramipexole—Visual disturbance—Varenicline—nicotine dependence	0.000761	0.00303	CcSEcCtD
Pramipexole—Atrial fibrillation—Varenicline—nicotine dependence	0.000761	0.00303	CcSEcCtD
Pramipexole—Thirst—Varenicline—nicotine dependence	0.000758	0.00301	CcSEcCtD
Pramipexole—HTR1B—brain—nicotine dependence	0.000752	0.0282	CbGeAlD
Pramipexole—Arthritis—Varenicline—nicotine dependence	0.000742	0.00295	CcSEcCtD
Pramipexole—Hypoglycaemia—Varenicline—nicotine dependence	0.000739	0.00294	CcSEcCtD
Pramipexole—HTR2A—cardiovascular system—nicotine dependence	0.000737	0.0276	CbGeAlD
Pramipexole—Lethargy—Varenicline—nicotine dependence	0.000736	0.00293	CcSEcCtD
Pramipexole—SLC22A1—brain—nicotine dependence	0.000734	0.0276	CbGeAlD
Pramipexole—HTR1D—brain—nicotine dependence	0.000728	0.0273	CbGeAlD
Pramipexole—Osteoarthritis—Varenicline—nicotine dependence	0.000722	0.00287	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.000722	0.00287	CcSEcCtD
Pramipexole—HTR2C—brain—nicotine dependence	0.000721	0.027	CbGeAlD
Pramipexole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000716	0.00284	CcSEcCtD
Pramipexole—Affect lability—Varenicline—nicotine dependence	0.00071	0.00282	CcSEcCtD
Pramipexole—Migraine—Varenicline—nicotine dependence	0.00071	0.00282	CcSEcCtD
Pramipexole—Psychotic disorder—Varenicline—nicotine dependence	0.000705	0.0028	CcSEcCtD
Pramipexole—Irritability—Varenicline—nicotine dependence	0.000689	0.00274	CcSEcCtD
Pramipexole—Urinary retention—Varenicline—nicotine dependence	0.000686	0.00273	CcSEcCtD
Pramipexole—Mood swings—Varenicline—nicotine dependence	0.000684	0.00272	CcSEcCtD
Pramipexole—HTR2B—brain—nicotine dependence	0.000677	0.0254	CbGeAlD
Pramipexole—ADRA2A—midbrain—nicotine dependence	0.000677	0.0254	CbGeAlD
Pramipexole—Dry skin—Varenicline—nicotine dependence	0.000661	0.00263	CcSEcCtD
Pramipexole—Abdominal pain upper—Varenicline—nicotine dependence	0.000659	0.00262	CcSEcCtD
Pramipexole—Hypokalaemia—Varenicline—nicotine dependence	0.000657	0.00261	CcSEcCtD
Pramipexole—Breast disorder—Varenicline—nicotine dependence	0.000652	0.00259	CcSEcCtD
Pramipexole—Cramp muscle—Varenicline—nicotine dependence	0.00065	0.00258	CcSEcCtD
Pramipexole—Nasopharyngitis—Varenicline—nicotine dependence	0.000645	0.00256	CcSEcCtD
Pramipexole—Gastritis—Varenicline—nicotine dependence	0.000639	0.00254	CcSEcCtD
Pramipexole—Abdominal distension—Varenicline—nicotine dependence	0.000628	0.00249	CcSEcCtD
Pramipexole—Dysphagia—Varenicline—nicotine dependence	0.000624	0.00248	CcSEcCtD
Pramipexole—Asthma—Varenicline—nicotine dependence	0.000624	0.00248	CcSEcCtD
Pramipexole—Angina pectoris—Varenicline—nicotine dependence	0.000607	0.00241	CcSEcCtD
Pramipexole—HTR1A—brain—nicotine dependence	0.000607	0.0228	CbGeAlD
Pramipexole—Bronchitis—Varenicline—nicotine dependence	0.0006	0.00238	CcSEcCtD
Pramipexole—Abdominal discomfort—Varenicline—nicotine dependence	0.000598	0.00238	CcSEcCtD
Pramipexole—Pollakiuria—Varenicline—nicotine dependence	0.000576	0.00229	CcSEcCtD
Pramipexole—HTR2A—midbrain—nicotine dependence	0.000575	0.0216	CbGeAlD
Pramipexole—Erectile dysfunction—Varenicline—nicotine dependence	0.000574	0.00228	CcSEcCtD
Pramipexole—Photosensitivity reaction—Varenicline—nicotine dependence	0.000569	0.00226	CcSEcCtD
Pramipexole—Weight increased—Varenicline—nicotine dependence	0.000568	0.00226	CcSEcCtD
Pramipexole—Hyperglycaemia—Varenicline—nicotine dependence	0.000563	0.00224	CcSEcCtD
Pramipexole—Infestation—Varenicline—nicotine dependence	0.000556	0.00221	CcSEcCtD
Pramipexole—Infestation NOS—Varenicline—nicotine dependence	0.000556	0.00221	CcSEcCtD
Pramipexole—Depression—Varenicline—nicotine dependence	0.000554	0.0022	CcSEcCtD
Pramipexole—DRD2—brain—nicotine dependence	0.000548	0.0206	CbGeAlD
Pramipexole—Acute coronary syndrome—Varenicline—nicotine dependence	0.000548	0.00218	CcSEcCtD
Pramipexole—Myocardial infarction—Varenicline—nicotine dependence	0.000545	0.00217	CcSEcCtD
Pramipexole—Conjunctivitis—Varenicline—nicotine dependence	0.00054	0.00215	CcSEcCtD
Pramipexole—ADRA2C—brain—nicotine dependence	0.000533	0.02	CbGeAlD
Pramipexole—Hepatobiliary disease—Varenicline—nicotine dependence	0.000526	0.00209	CcSEcCtD
Pramipexole—Epistaxis—Varenicline—nicotine dependence	0.000524	0.00208	CcSEcCtD
Pramipexole—Sinusitis—Varenicline—nicotine dependence	0.000522	0.00207	CcSEcCtD
Pramipexole—Bradycardia—Varenicline—nicotine dependence	0.000508	0.00202	CcSEcCtD
Pramipexole—Hypoaesthesia—Varenicline—nicotine dependence	0.000497	0.00197	CcSEcCtD
Pramipexole—Hallucination—Varenicline—nicotine dependence	0.000497	0.00197	CcSEcCtD
Pramipexole—Urinary tract disorder—Varenicline—nicotine dependence	0.000493	0.00196	CcSEcCtD
Pramipexole—Oedema peripheral—Varenicline—nicotine dependence	0.000492	0.00195	CcSEcCtD
Pramipexole—Connective tissue disorder—Varenicline—nicotine dependence	0.000491	0.00195	CcSEcCtD
Pramipexole—Urethral disorder—Varenicline—nicotine dependence	0.000489	0.00194	CcSEcCtD
Pramipexole—Visual impairment—Varenicline—nicotine dependence	0.000481	0.00191	CcSEcCtD
Pramipexole—Eye disorder—Varenicline—nicotine dependence	0.000466	0.00185	CcSEcCtD
Pramipexole—Tinnitus—Varenicline—nicotine dependence	0.000465	0.00185	CcSEcCtD
Pramipexole—Cardiac disorder—Varenicline—nicotine dependence	0.000463	0.00184	CcSEcCtD
Pramipexole—Angiopathy—Varenicline—nicotine dependence	0.000453	0.0018	CcSEcCtD
Pramipexole—Immune system disorder—Varenicline—nicotine dependence	0.000451	0.00179	CcSEcCtD
Pramipexole—Mediastinal disorder—Varenicline—nicotine dependence	0.00045	0.00179	CcSEcCtD
Pramipexole—Chills—Varenicline—nicotine dependence	0.000448	0.00178	CcSEcCtD
Pramipexole—Mental disorder—Varenicline—nicotine dependence	0.000437	0.00174	CcSEcCtD
Pramipexole—Erythema—Varenicline—nicotine dependence	0.000435	0.00173	CcSEcCtD
Pramipexole—Malnutrition—Varenicline—nicotine dependence	0.000435	0.00173	CcSEcCtD
Pramipexole—Flatulence—Varenicline—nicotine dependence	0.000428	0.0017	CcSEcCtD
Pramipexole—Dysgeusia—Varenicline—nicotine dependence	0.000426	0.00169	CcSEcCtD
Pramipexole—ADRA2A—brain—nicotine dependence	0.000425	0.016	CbGeAlD
Pramipexole—Back pain—Varenicline—nicotine dependence	0.00042	0.00167	CcSEcCtD
Pramipexole—Muscle spasms—Varenicline—nicotine dependence	0.000418	0.00166	CcSEcCtD
Pramipexole—Vision blurred—Varenicline—nicotine dependence	0.00041	0.00163	CcSEcCtD
Pramipexole—Tremor—Varenicline—nicotine dependence	0.000407	0.00162	CcSEcCtD
Pramipexole—Ill-defined disorder—Varenicline—nicotine dependence	0.000403	0.0016	CcSEcCtD
Pramipexole—Anaemia—Varenicline—nicotine dependence	0.000402	0.0016	CcSEcCtD
Pramipexole—Agitation—Varenicline—nicotine dependence	0.000399	0.00159	CcSEcCtD
Pramipexole—Malaise—Varenicline—nicotine dependence	0.000392	0.00156	CcSEcCtD
Pramipexole—Vertigo—Varenicline—nicotine dependence	0.00039	0.00155	CcSEcCtD
Pramipexole—Syncope—Varenicline—nicotine dependence	0.00039	0.00155	CcSEcCtD
Pramipexole—Palpitations—Varenicline—nicotine dependence	0.000384	0.00153	CcSEcCtD
Pramipexole—Loss of consciousness—Varenicline—nicotine dependence	0.000382	0.00152	CcSEcCtD
Pramipexole—Cough—Varenicline—nicotine dependence	0.000379	0.00151	CcSEcCtD
Pramipexole—Convulsion—Varenicline—nicotine dependence	0.000376	0.0015	CcSEcCtD
Pramipexole—Hypertension—Varenicline—nicotine dependence	0.000375	0.00149	CcSEcCtD
Pramipexole—Chest pain—Varenicline—nicotine dependence	0.00037	0.00147	CcSEcCtD
Pramipexole—Myalgia—Varenicline—nicotine dependence	0.00037	0.00147	CcSEcCtD
Pramipexole—Arthralgia—Varenicline—nicotine dependence	0.00037	0.00147	CcSEcCtD
Pramipexole—Anxiety—Varenicline—nicotine dependence	0.000369	0.00147	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000367	0.00146	CcSEcCtD
Pramipexole—Discomfort—Varenicline—nicotine dependence	0.000366	0.00145	CcSEcCtD
Pramipexole—Dry mouth—Varenicline—nicotine dependence	0.000362	0.00144	CcSEcCtD
Pramipexole—HTR2A—brain—nicotine dependence	0.000362	0.0136	CbGeAlD
Pramipexole—Oedema—Varenicline—nicotine dependence	0.000355	0.00141	CcSEcCtD
Pramipexole—Infection—Varenicline—nicotine dependence	0.000352	0.0014	CcSEcCtD
Pramipexole—Shock—Varenicline—nicotine dependence	0.000349	0.00139	CcSEcCtD
Pramipexole—Nervous system disorder—Varenicline—nicotine dependence	0.000348	0.00138	CcSEcCtD
Pramipexole—Thrombocytopenia—Varenicline—nicotine dependence	0.000347	0.00138	CcSEcCtD
Pramipexole—Tachycardia—Varenicline—nicotine dependence	0.000346	0.00138	CcSEcCtD
Pramipexole—Skin disorder—Varenicline—nicotine dependence	0.000344	0.00137	CcSEcCtD
Pramipexole—Hyperhidrosis—Varenicline—nicotine dependence	0.000343	0.00136	CcSEcCtD
Pramipexole—Anorexia—Varenicline—nicotine dependence	0.000338	0.00134	CcSEcCtD
Pramipexole—Hypotension—Varenicline—nicotine dependence	0.000331	0.00132	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000323	0.00128	CcSEcCtD
Pramipexole—Insomnia—Varenicline—nicotine dependence	0.000321	0.00127	CcSEcCtD
Pramipexole—Dyspnoea—Varenicline—nicotine dependence	0.000316	0.00126	CcSEcCtD
Pramipexole—Somnolence—Varenicline—nicotine dependence	0.000315	0.00125	CcSEcCtD
Pramipexole—Dyspepsia—Varenicline—nicotine dependence	0.000312	0.00124	CcSEcCtD
Pramipexole—Decreased appetite—Varenicline—nicotine dependence	0.000308	0.00123	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000306	0.00122	CcSEcCtD
Pramipexole—Fatigue—Varenicline—nicotine dependence	0.000306	0.00122	CcSEcCtD
Pramipexole—Pain—Varenicline—nicotine dependence	0.000303	0.00121	CcSEcCtD
Pramipexole—Constipation—Varenicline—nicotine dependence	0.000303	0.00121	CcSEcCtD
Pramipexole—Feeling abnormal—Varenicline—nicotine dependence	0.000292	0.00116	CcSEcCtD
Pramipexole—Gastrointestinal pain—Varenicline—nicotine dependence	0.00029	0.00115	CcSEcCtD
Pramipexole—Urticaria—Varenicline—nicotine dependence	0.000282	0.00112	CcSEcCtD
Pramipexole—Body temperature increased—Varenicline—nicotine dependence	0.00028	0.00111	CcSEcCtD
Pramipexole—Abdominal pain—Varenicline—nicotine dependence	0.00028	0.00111	CcSEcCtD
Pramipexole—Hypersensitivity—Varenicline—nicotine dependence	0.000261	0.00104	CcSEcCtD
Pramipexole—Asthenia—Varenicline—nicotine dependence	0.000254	0.00101	CcSEcCtD
Pramipexole—Pruritus—Varenicline—nicotine dependence	0.000251	0.000997	CcSEcCtD
Pramipexole—Diarrhoea—Varenicline—nicotine dependence	0.000243	0.000964	CcSEcCtD
Pramipexole—Dizziness—Varenicline—nicotine dependence	0.000235	0.000932	CcSEcCtD
Pramipexole—Vomiting—Varenicline—nicotine dependence	0.000225	0.000896	CcSEcCtD
Pramipexole—Rash—Varenicline—nicotine dependence	0.000224	0.000889	CcSEcCtD
Pramipexole—Dermatitis—Varenicline—nicotine dependence	0.000223	0.000888	CcSEcCtD
Pramipexole—Headache—Varenicline—nicotine dependence	0.000222	0.000883	CcSEcCtD
Pramipexole—Nausea—Varenicline—nicotine dependence	0.000211	0.000837	CcSEcCtD
Pramipexole—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.00016	0.00127	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000159	0.00126	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000159	0.00126	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000158	0.00126	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000158	0.00126	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000158	0.00126	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.00125	CbGpPWpGaD
Pramipexole—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000157	0.00125	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000156	0.00124	CbGpPWpGaD
Pramipexole—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000155	0.00123	CbGpPWpGaD
Pramipexole—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.000155	0.00123	CbGpPWpGaD
Pramipexole—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000155	0.00123	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000155	0.00123	CbGpPWpGaD
Pramipexole—DRD5—GPCR ligand binding—DRD2—nicotine dependence	0.000154	0.00122	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000153	0.00122	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TAS2R16—nicotine dependence	0.000153	0.00122	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.000153	0.00121	CbGpPWpGaD
Pramipexole—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000152	0.00121	CbGpPWpGaD
Pramipexole—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000151	0.0012	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.00119	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00015	0.00119	CbGpPWpGaD
Pramipexole—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00119	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000149	0.00118	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000148	0.00118	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000147	0.00117	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.000147	0.00117	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000147	0.00117	CbGpPWpGaD
Pramipexole—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000145	0.00116	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000144	0.00115	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000143	0.00114	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000143	0.00114	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000143	0.00114	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000143	0.00114	CbGpPWpGaD
Pramipexole—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000142	0.00113	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000142	0.00113	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000141	0.00112	CbGpPWpGaD
Pramipexole—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000141	0.00112	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00014	0.00112	CbGpPWpGaD
Pramipexole—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00014	0.00111	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.00014	0.00111	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000138	0.0011	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000135	0.00108	CbGpPWpGaD
Pramipexole—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000135	0.00107	CbGpPWpGaD
Pramipexole—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000134	0.00107	CbGpPWpGaD
Pramipexole—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000134	0.00107	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000134	0.00106	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000133	0.00106	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000133	0.00105	CbGpPWpGaD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000133	0.00105	CbGpPWpGaD
Pramipexole—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000131	0.00104	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00013	0.00103	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000128	0.00102	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000128	0.00102	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000128	0.00102	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000127	0.00101	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000126	0.001	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000126	0.000999	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000124	0.000985	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000122	0.000968	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000121	0.000963	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00012	0.000958	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—OPRM1—nicotine dependence	0.00012	0.000957	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—FGD1—nicotine dependence	0.00012	0.000956	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00012	0.000952	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000938	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000118	0.000937	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000117	0.000933	CbGpPWpGaD
Pramipexole—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000117	0.000927	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000116	0.000926	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000116	0.000925	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000116	0.00092	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000116	0.000919	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000116	0.000919	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000115	0.000914	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.000914	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000114	0.000908	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000114	0.000904	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.000899	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000113	0.000895	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000112	0.000894	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000112	0.000889	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000111	0.00088	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000109	0.000869	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000109	0.000863	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000108	0.000858	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.00085	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.000106	0.000845	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000106	0.000843	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000105	0.000836	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000102	0.000814	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000812	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.00081	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000101	0.000803	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000101	0.0008	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.0001	0.000799	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.0001	0.000799	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.98e-05	0.000794	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.57e-05	0.000761	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	9.22e-05	0.000733	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—FGD1—nicotine dependence	9.21e-05	0.000732	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.14e-05	0.000727	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	9.12e-05	0.000725	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.08e-05	0.000722	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	9.07e-05	0.000721	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.03e-05	0.000718	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.02e-05	0.000717	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	8.88e-05	0.000707	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—FGD1—nicotine dependence	8.87e-05	0.000706	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.8e-05	0.0007	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.75e-05	0.000696	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.75e-05	0.000696	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.71e-05	0.000693	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	8.7e-05	0.000692	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.51e-05	0.000677	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.48e-05	0.000675	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.47e-05	0.000674	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.47e-05	0.000674	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	8.37e-05	0.000666	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.2e-05	0.000652	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	8.13e-05	0.000647	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.07e-05	0.000642	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8e-05	0.000636	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—FGD1—nicotine dependence	7.99e-05	0.000635	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	7.96e-05	0.000633	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—DRD2—nicotine dependence	7.9e-05	0.000629	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	7.89e-05	0.000628	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—FGD1—nicotine dependence	7.88e-05	0.000627	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	7.84e-05	0.000623	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.7e-05	0.000613	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.68e-05	0.000611	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.6e-05	0.000605	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.56e-05	0.000601	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.48e-05	0.000595	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—WASF2—nicotine dependence	7.48e-05	0.000595	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.26e-05	0.000578	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—WASF1—nicotine dependence	7.17e-05	0.00057	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.17e-05	0.00057	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.13e-05	0.000567	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	7.11e-05	0.000566	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.06e-05	0.000561	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	6.96e-05	0.000554	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	6.92e-05	0.00055	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	6.88e-05	0.000547	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.88e-05	0.000547	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.87e-05	0.000546	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.84e-05	0.000544	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.83e-05	0.000543	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CYP2A7—nicotine dependence	6.71e-05	0.000534	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	6.67e-05	0.00053	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.66e-05	0.000529	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.65e-05	0.000529	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.53e-05	0.000519	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.53e-05	0.000519	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.47e-05	0.000515	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—OPRM1—nicotine dependence	6.46e-05	0.000514	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.42e-05	0.000511	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.28e-05	0.0005	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CYP2A7—nicotine dependence	6.25e-05	0.000497	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.25e-05	0.000497	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.21e-05	0.000494	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	6.13e-05	0.000488	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.07e-05	0.000483	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	6.05e-05	0.000482	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	6.04e-05	0.000481	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.04e-05	0.00048	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.04e-05	0.00048	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.03e-05	0.00048	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.94e-05	0.000473	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.93e-05	0.000472	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	5.93e-05	0.000471	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.87e-05	0.000467	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.83e-05	0.000464	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.78e-05	0.00046	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—WASF2—nicotine dependence	5.73e-05	0.000456	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.71e-05	0.000454	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.61e-05	0.000446	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.57e-05	0.000443	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.52e-05	0.000439	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.49e-05	0.000437	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.48e-05	0.000436	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.41e-05	0.00043	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.4e-05	0.000429	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.4e-05	0.000429	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.38e-05	0.000428	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.33e-05	0.000424	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.3e-05	0.000422	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.29e-05	0.000421	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.27e-05	0.000419	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.25e-05	0.000418	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.24e-05	0.000417	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.18e-05	0.000412	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5.15e-05	0.00041	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—WASF1—nicotine dependence	5.05e-05	0.000402	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.97e-05	0.000396	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—WASF2—nicotine dependence	4.97e-05	0.000395	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.95e-05	0.000393	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	4.95e-05	0.000393	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.91e-05	0.00039	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.9e-05	0.00039	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.84e-05	0.000385	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.81e-05	0.000383	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.77e-05	0.000379	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.77e-05	0.000379	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.77e-05	0.000379	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.7e-05	0.000374	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.68e-05	0.000372	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD2—nicotine dependence	4.67e-05	0.000371	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.55e-05	0.000362	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.52e-05	0.000359	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.49e-05	0.000357	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.43e-05	0.000352	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.37e-05	0.000348	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.3e-05	0.000342	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.29e-05	0.000341	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.27e-05	0.00034	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.25e-05	0.000338	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.25e-05	0.000338	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.23e-05	0.000337	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.14e-05	0.000329	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.1e-05	0.000326	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.08e-05	0.000324	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.97e-05	0.000315	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.91e-05	0.000311	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.9e-05	0.00031	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.82e-05	0.000304	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.75e-05	0.000298	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.69e-05	0.000294	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.69e-05	0.000293	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.67e-05	0.000292	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.6e-05	0.000286	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.58e-05	0.000284	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.57e-05	0.000284	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.55e-05	0.000282	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.54e-05	0.000282	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.5e-05	0.000279	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.45e-05	0.000274	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.36e-05	0.000267	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.29e-05	0.000262	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000258	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.22e-05	0.000256	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.19e-05	0.000254	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.1e-05	0.000247	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.06e-05	0.000243	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.9e-05	0.000231	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.76e-05	0.00022	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.67e-05	0.000212	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.65e-05	0.000211	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.58e-05	0.000205	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.3e-05	0.000183	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.1e-05	0.000167	CbGpPWpGaD
